Cargando…

Correlation between the Outcome of Vitrectomy for Proliferative Diabetic Retinopathy and Erythrocyte Hematocrit Level and Platelet Function

We investigate-d whether biomarkers such as red blood cell hematocrit (Hct), platelet count (PLT), mean platelet volume (MPV), and platelet distribution width (PDW) are useful prognostic indicators of postoperative macular edema (ME) after vitrectomy for proliferative diabetic retinopathy (PDR). A t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Keiji, Jujo, Tatsuya, Sekine, Reio, Uchiyama, Naoto, Kakehashi, Kota, Kogo, Jiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457308/ https://www.ncbi.nlm.nih.gov/pubmed/36078984 http://dx.doi.org/10.3390/jcm11175055

Ejemplares similares

Comparative study of straight vs angled incision in 27-gauge vitrectomy for epiretinal membrane
por: Yomoda, Ryo, et al.
Publicado: (2018)

27-gauge trocar-assisted sutureless intraocular lens fixation
por: Jujo, Tatsuya, et al.
Publicado: (2021)

Refining vitrectomy for proliferative diabetic retinopathy
por: Chen, San-Ni, et al.
Publicado: (2023)

Vitrectomy for Proliferative Diabetic Retinopathy Associated with Klinefelter Syndrome
por: Tajiri, Kensuke, et al.
Publicado: (2015)

Long‐term outcomes of vitrectomy for proliferative diabetic retinopathy
por: Schreur, Vivian, et al.
Publicado: (2020)

Iatrogenic retinal breaks during 20-gauge vitrectomy for proliferative diabetic retinopathy
por: Kamura, Yumi, et al.
Publicado: (2013)

Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy
por: Kwon, Jin-woo, et al.
Publicado: (2017)

Pars Plana Vitrectomy Reoperations for Complications of Proliferative Diabetic Retinopathy
por: Al-khersan, Hasenin, et al.
Publicado: (2020)

Post-vitrectomy delayed retinal breaks in proliferative diabetic retinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023)

Early Vitreous Hemorrhage after Vitrectomy with Preoperative Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
por: Sato, Tatsuhiko, et al.
Publicado: (2013)

Axonal Protection by Oral Nicotinamide Riboside Treatment with Upregulated AMPK Phosphorylation in a Rat Glaucomatous Degeneration Model
por: Arizono, Ibuki, et al.
Publicado: (2023)

Vitrectomy for Proliferative Diabetic Retinopathy in a Patient with Heparin-Induced Thrombocytopenia
por: Fujii, Tomoko, et al.
Publicado: (2016)

Evaluation of twenty-seven-gauge vitrectomy for complex proliferative diabetic retinopathy
por: Verma, Saurabh, et al.
Publicado: (2023)

Two Cases of Proliferative Diabetic Retinopathy with Marked Sheathing of the Retinal Arteries following Vitrectomy
por: Nishikawa, Yuko, et al.
Publicado: (2017)

Faster recovery after 25-gauge microincision vitrectomy surgery than after 20-gauge vitrectomy in patients with proliferative diabetic retinopathy
por: Sato, Tatsuhiko, et al.
Publicado: (2012)

Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
por: Sakamoto, Masashi, et al.
Publicado: (2018)

Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients
por: Liao, Mengyu, et al.
Publicado: (2020)

Is Chronic Kidney Disease Affecting the Postoperative Complications of Vitrectomy for Proliferative Diabetic Retinopathy?
por: Kameda, Yusuke, et al.
Publicado: (2021)

Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review
por: Dervenis, Panagiotis, et al.
Publicado: (2021)

Commentary: Vitrectomy for proliferative diabetic retinopathy in patients with type 1 diabetes mellitus
por: Tekchandani, Uday, et al.
Publicado: (2021)

Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy
por: Wang, Weiwei, et al.
Publicado: (2023)

27‑Gauge vitrectomy vs. 25‑gauge vitrectomy in the management of proliferative diabetic retinopathy with preoperative intravitreal injection of conbercept
por: Xiang, Wu, et al.
Publicado: (2023)

Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy
por: Zaman, Yawar, et al.
Publicado: (2013)

A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy
por: Yang, Xiaochun, et al.
Publicado: (2016)

Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy
por: Sakamoto, Masashi, et al.
Publicado: (2018)

Predictive risk factors for exudative retinal detachment after vitrectomy for proliferative diabetic retinopathy
por: Sun, Di-Fang, et al.
Publicado: (2019)

Same-Day Cancellation is Higher in Outpatient Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
por: Xi, Chunhua, et al.
Publicado: (2022)

Predictors of visual outcome after pars plana vitrectomy secondary to proliferative diabetic retinopathy
por: Nisic, Faruk, et al.
Publicado: (2023)

Progression of nuclear sclerosis based on changes in refractive values after lens-sparing vitrectomy in proliferative diabetic retinopathy
por: Ikeda, Tsunehiko, et al.
Publicado: (2014)

Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab
por: Shiono, Akira, et al.
Publicado: (2018)

HEMI-TEMPORAL INTERNAL LIMITING MEMBRANE PEELING IS AS EFFECTIVE AND SAFE AS CONVENTIONAL FULL PEELING FOR MACULAR HOLE SURGERY
por: Shiono, Akira, et al.
Publicado: (2019)

Vitreous and Plasma VEGF Levels as Predictive Factors in the Progression of Proliferative Diabetic Retinopathy after Vitrectomy
por: Wang, Jiaxing, et al.
Publicado: (2014)

Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
por: Demir, Mehmet, et al.
Publicado: (2013)

Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy [Corrigendum]
Publicado: (2018)

Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye?
por: Xu, Wei, et al.
Publicado: (2019)

Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy
por: Someya, Hideaki, et al.
Publicado: (2019)

Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy
por: Chen, Hui-Jin, et al.
Publicado: (2019)

Recovery of visual field defects following vitrectomy for proliferative diabetic retinopathy: A case report
por: Lo, Kang-Jung, et al.
Publicado: (2021)

Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy
por: Ding, Yuzhi, et al.
Publicado: (2023)

Effect of plateletpheresis on hematocrit, hemoglobin and erythrocyte count: Meta-analysis 1980–2018
por: Gil-Betacur, Alejandro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s8l4klvgvl2d0898u4e66eo5b7